Intrinsiqs

Is Gilead Sciences, Inc. overvalued?

Gilead Sciences, Inc. (GILD) looks fairly valued — trading about 5% above its fair value.

Fairly valued
Current price $127.88 Fair value $121.32
Price
$127.88
Fair value
$121.32
Current P/E
18.9
Normal P/E
17.9
Market cap
$158.77B
Dividend yield
2.6%
Return on equity
37.5%
Sector
Healthcare

See the full interactive analysis →

Fair value compares GILD's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 28 Jun 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.UNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.AMGN Amgen Inc.